neostigmine has been researched along with Hypoglycemia in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lick, RF | 1 |
Endriss, R | 1 |
Hart, W | 1 |
Balser, D | 1 |
Riffelmacher, R | 1 |
1 other study available for neostigmine and Hypoglycemia
Article | Year |
---|---|
[On the effect of insulin on stimulated secretion in the vagally innervated and denervated gastric segment. Secretion studies in gastric fistula dogs].
Topics: Animals; Depression, Chemical; Dogs; Gastric Juice; Gastric Mucosa; Gastrins; Gastrostomy; Hexoses; | 1968 |